Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CABIO is a leading Chinese biotechnology company specializing in the industrial-scale production of nutritional ingredients such as Arachidonic acid (ARA), Docosahexaenoic acid (DHA), β-carotene, and N-acetylneuraminic acid using advanced synthetic biology and microbial fermentation technologies. Its products are widely used in infant formula, dietary supplements, clinical nutrition foods, animal nutrition, and personal care. The company has achieved international certifications including FDA GRAS status for its ARA/DHA products and USDA Organic certification for its algal DHA oil. It operates one of the world’s largest LCPUFA manufacturing plants with robust supply chain capabilities.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CABIO Biotech.